Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents.
Juvvadi, P.R., Fox 3rd, D., Bobay, B.G., Hoy, M.J., Gobeil, S.M.C., Venters, R.A., Chang, Z., Lin, J.J., Averette, A.F., Cole, D.C., Barrington, B.C., Wheaton, J.D., Ciofani, M., Trzoss, M., Li, X., Lee, S.C., Chen, Y.L., Mutz, M., Spicer, L.D., Schumacher, M.A., Heitman, J., Steinbach, W.J.(2019) Nat Commun 10: 4275-4275
- PubMed: 31537789 
- DOI: 10.1038/s41467-019-12199-1
- Primary Citation of Related Structures:  
5B8I, 6TZ6, 6TZ7, 6TZ8 - PubMed Abstract: 
Calcineurin is important for fungal virulence and a potential antifungal target, but compounds targeting calcineurin, such as FK506, are immunosuppressive. Here we report the crystal structures of calcineurin catalytic (CnA) and regulatory (CnB) subunits complexed with FK506 and the FK506-binding protein (FKBP12) from human fungal pathogens (Aspergillus fumigatus, Candida albicans, Cryptococcus neoformans and Coccidioides immitis) ...